Article

High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse.

Department of Cell & Molecular Physiology, University of North Carolina at Chapel Hill, North Carolina, United States of America.
PLoS ONE (Impact Factor: 3.53). 08/2010; 5(8):e12191. DOI: 10.1371/journal.pone.0012191
Source: PubMed

ABSTRACT Obesity induced by high fat (HF) diet is associated with inflammation which contributes to development of insulin resistance. Most prior studies have focused on adipose tissue as the source of obesity-associated inflammation. Increasing evidence links intestinal bacteria to development of diet-induced obesity (DIO). This study tested the hypothesis that HF western diet and gut bacteria interact to promote intestinal inflammation, which contributes to the progression of obesity and insulin resistance.
Conventionally raised specific-pathogen free (CONV) and germ-free (GF) mice were given HF or low fat (LF) diet for 2-16 weeks. Body weight and adiposity were measured. Intestinal inflammation was assessed by evaluation of TNF-alpha mRNA and activation of a NF-kappaB(EGFP) reporter gene. In CONV but not GF mice, HF diet induced increases in body weight and adiposity. HF diet induced ileal TNF-alpha mRNA in CONV but not GF mice and this increase preceded obesity and strongly and significantly correlated with diet induced weight gain, adiposity, plasma insulin and glucose. In CONV mice HF diet also resulted in activation of NF-kappaB(EGFP) in epithelial cells, immune cells and endothelial cells of small intestine. Further experiments demonstrated that fecal slurries from CONV mice fed HF diet are sufficient to activate NF-kappaB(EGFP) in GF NF-kappaB(EGFP) mice.
Bacteria and HF diet interact to promote proinflammatory changes in the small intestine, which precede weight gain and obesity and show strong and significant associations with progression of obesity and development of insulin resistance. To our knowledge, this is the first evidence that intestinal inflammation is an early consequence of HF diet which may contribute to obesity and associated insulin resistance. Interventions which limit intestinal inflammation induced by HF diet and bacteria may protect against obesity and insulin resistance.

2 Followers
 · 
121 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Important current diseases manifest to cover metabolic diseases, respiratory allergies, gastrointestinal (GI) diseases, genital infections, certain neurological disorders, autoimmune disorders, and musculoskeletal pain and fatigue. Patients with these diseases have been known to respond favorably to a treatment method of increasing dosages of composite selective probiotics, (probiotics and paraprobiotics) and probiotical cell fragments (PCFs) supplements. PCFs such as of lactobacilli and bifidobacteria benefit the GI system and have shown substantial local immune enhancing benefits. These treatment methods have demonstrated positive results in 85.5% of cases of chronic tonsillitis and 90% in maxilloethmoidal sinusitis. Consistent amounts of probiotics have been quantified for therapeutic microbial activities on a broad spectrum of pathogenic Candida species in otolaryngology and genital organs, respectively. The combined effects of this article enable selective probiotics and their derivatives as valuable tools for clinical employment in the prevention and adjunctive treatment of significant current diseases.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Obesity has reached epidemic proportions, but little is known about its influence on the intestinal immune system. Here we show that the gut immune system is altered during high-fat diet (HFD) feeding and is a functional regulator of obesity-related insulin resistance (IR) that can be exploited therapeutically. Obesity induces a chronic phenotypic pro-inflammatory shift in bowel lamina propria immune cell populations. Reduction of the gut immune system, using beta7 integrin-deficient mice (Beta7(null)), decreases HFD-induced IR. Treatment of wild-type HFD C57BL/6 mice with the local gut anti-inflammatory, 5-aminosalicyclic acid (5-ASA), reverses bowel inflammation and improves metabolic parameters. These beneficial effects are dependent on adaptive and gut immunity and are associated with reduced gut permeability and endotoxemia, decreased visceral adipose tissue inflammation, and improved antigen-specific tolerance to luminal antigens. Thus, the mucosal immune system affects multiple pathways associated with systemic IR and represents a novel therapeutic target in this disease. Copyright © 2015 Elsevier Inc. All rights reserved.
    Cell metabolism 04/2015; 21(4):527-542. DOI:10.1016/j.cmet.2015.03.001 · 16.75 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Large-scale codon re-encoding (i.e. introduction of a large number of synonymous mutations) is a novel method of generating attenuated viruses. Here, it was applied to the patho-genic flavivirus, tick-borne encephalitis virus (TBEV) which causes febrile illness and encephalitis in humans in forested regions of Europe and Asia. Using an infectious clone of the Oshima 5–10 strain ("wild-type virus"), a cassette of 1.4kb located in the NS5 coding region , was modified by randomly introducing 273 synonymous mutations ("re-encoded virus"). Whilst the in cellulo replicative fitness of the re-encoded virus was only slightly reduced , the re-encoded virus displayed an attenuated phenotype in a laboratory mouse model of non-lethal encephalitis. Following intra-peritoneal inoculation of either 2.10 5 or 2.10 6 TCID50 of virus, the frequency of viraemia, neurovirulence (measured using weight
    PLoS Pathogens 03/2015; 11(3). DOI:10.1371/journal.ppat.1004738 · 8.14 Impact Factor

Full-text (2 Sources)

Download
60 Downloads
Available from
May 23, 2014